Arca
Skip to content

HTR3A: 5-hydroxytryptamine receptor 3A

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Forms serotonin (5-hydroxytryptamine/5-HT3)-activated cation- selective channel complexes, which when activated cause fast, depolarizing responses in neurons. {ECO:0000269|PubMed:10521471, ECO:0000269|PubMed:12867984, ECO:0000269|PubMed:17392525, ECO:0000269|PubMed:9950429}.

  • Drugs that act on it: 7
  • With a US drug page: 5
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page
AlosetronApprovedSerotonin 3a (5-HT3a) receptor antagonistAntagonistBoxed warning
DolasetronApprovedSerotonin 3a (5-HT3a) receptor antagonistAntagonist—
MetoclopramideApprovedSerotonin 3a (5-HT3a) receptor antagonistAntagonistBoxed warning
PalonosetronApprovedSerotonin 3a (5-HT3a) receptor antagonistAntagonist—
VortioxetineApprovedSerotonin 3a (5-HT3a) receptor antagonistAntagonistBoxed warning
Granisetron—Serotonin 3a (5-HT3a) receptor antagonistAntagonist—
Ondansetron—Serotonin 3a (5-HT3a) receptor antagonistAntagonist—

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
Chemotherapy-induced nausea and vomiting
0.61
Post operative nausea and vomiting
0.60
Nausea
0.60
Cancer
0.60
Gastrointestinal disease
0.53

Genes and Related Targets

Complexes and families that share a gene with this target
Genes
HTR3A

Drugs and mechanisms are from ChEMBL CHEMBL1899 (CC BY-SA 3.0). Gene name, function (UniProt P46098, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.